Key result
Drug and non-drug interventions to prevent or treat cardiac complications in DMD, BMD, and XLDCM will be assessed for efficacy in this Cochrane review protocol.
Why the study?
Do drug and non-drug interventions prevent or treat cardiac complications in patients with DMD, BMD, and XLDCM?
Do drug and non-drug interventions prevent or treat cardiac complications in patients with DMD, BMD, and XLDCM?
Answers are grounded in this paper and cite their sources.
This protocol outlines a planned Cochrane Review to evaluate interventions for cardiac complications in muscular dystrophies and X-linked dilated cardiomyopathy.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess efficacy of interventions (drug and non‐drug) to prevent or treat cardiac complications in DMD, BMD and XLDCM.
No takes yet. Share an insight, caveat, or question.
Quinlivan et al. (2012) studied this question. Drug and non-drug interventions to prevent or treat cardiac complications in DMD, BMD, and XLDCM will be assessed for efficacy in this Cochrane review protocol.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: